Ellele Health Limited is registered in England and Wales with Company #12764037
Registered office First Floor, 5 Fleet Place, London, United Kingdom, EC4M 7RD
The primary objective of the study was to assess the feasibility of collecting a vaginal sample using the Ellele Device.
Planned to commence early 2025 with a primary objective to determine the ability to detect ovarian and endometrial cancer and a secondary objective to look at a range of other conditions, building a sample biobank.
If you have been asked to take part in one of these studies, please ensure you read the information that has been given to you and address any queries or concerns you may have to either the study lead doctor or any other clinical professional involved in the study.
Unfortunately, the staff at Ellele Health and Origin Sciences are unable to communicate directly with study participants or potential participants and are unable to provide any advice regarding the study.
All active studies have full and relevant ethical approval and have been carefully designed to ensure safe delivery. Participating in our studies is always optional, and participation can be withdrawn at any time.
Patient participation is extremely valuable in helping us to understand gynaecological health and deliver new diagnostic solutions with the ultimate aim of saving lives through early disease detection.
Ellele Health Limited is registered in England and Wales with Company #12764037
Registered office First Floor, 5 Fleet Place, London, United Kingdom, EC4M 7RD